FDA Approved: HYDROXYCHLOROQUINE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for HYDROXYCHLOROQUINE from Chartwell RX, LLC under an ANDA, making a generic version available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

SUPPL AP for HYDROXYCHLOROQUINE (HYDROXYCHLOROQUINE)